S A Guidera1, J S Steinberg. 1. Division of Cardiology, Columbia-Presbyterian Medical Center, New York, New York.
Abstract
OBJECTIVES: This study was undertaken to determine the ability of the signal-averaged electrocardiogram (ECG) to identify evidence of delayed atrial activation in patients with a history of atrial fibrillation. BACKGROUND: Atrial fibrillation is a reentrant rhythm and depends on atrial conduction delay for its development. The signal-averaging technique is useful for accurately measuring total cardiac activation times, including delayed low amplitude signals, and thus can help identify the substrate for reentrant arrhythmias. METHODS: Standard 12-lead and signal-averaged ECGs were recorded from 15 patients with a documented history of prior paroxysmal or chronic atrial fibrillation and 15 age- and disease-matched control subjects without a history of atrial fibrillation. Signal averaging was performed using an orthogonal lead system with the QRS complex as a trigger and the P wave as a template for the signal-averaging process. Total P wave duration was measured before and after filtering with a least squares fit filter. The P wave complexes on the three bipolar leads were combined into a vector combination of orthogonal leads. The total P wave duration of the individual unfiltered and filtered leads and the vector combination of filtered leads were calculated and used for analysis. RESULTS: The P wave duration by standard ECG was not significantly different in patients with a history of atrial fibrillation and control subjects. Signal-averaged P wave durations were measured from orthogonal leads before and after digital filtering. Mean unfiltered P wave duration was significantly longer in patients with a history of atrial fibrillation than in control subjects (132 +/- 22 vs. 114 +/- 14 ms [p < 0.03] in the X lead, 135 +/- 21 vs. 115 +/- 15 ms [p < 0.03] in the Y lead and 133 +/- 23 vs. 114 +/- 14 ms [p < 0.03] in the Z lead). Mean filtered P wave duration was also longer in patients with atrial fibrillation than in control subjects (151 +/- 23 vs. 130 +/- 19 ms [p < 0.01] in the X lead, 157 +/- 22 vs. 136 +/- 17 ms [p < 0.01] in the Y lead and 154 +/- 23 vs. 135 +/- 15 ms [p < 0.01] in the Z lead). After filtering, a vector composite of orthogonal leads was determined. Again, P wave duration in patients with a history of atrial fibrillation exceeded that in the control subjects (162 +/- 15 vs. 140 +/- 12 ms [p < 0.01]). Using the vector composite of filtered orthogonal leads, a P wave duration > or = 155 ms was associated with a sensitivity of 80%, a specificity of 93% and a positive predictive value of 92% for identifying patients with history of atrial fibrillation. CONCLUSIONS: A prolonged signal-averaged P wave duration may be a simple noninvasive marker of the risk for development of atrial fibrillation.
OBJECTIVES: This study was undertaken to determine the ability of the signal-averaged electrocardiogram (ECG) to identify evidence of delayed atrial activation in patients with a history of atrial fibrillation. BACKGROUND:Atrial fibrillation is a reentrant rhythm and depends on atrial conduction delay for its development. The signal-averaging technique is useful for accurately measuring total cardiac activation times, including delayed low amplitude signals, and thus can help identify the substrate for reentrant arrhythmias. METHODS: Standard 12-lead and signal-averaged ECGs were recorded from 15 patients with a documented history of prior paroxysmal or chronic atrial fibrillation and 15 age- and disease-matched control subjects without a history of atrial fibrillation. Signal averaging was performed using an orthogonal lead system with the QRS complex as a trigger and the P wave as a template for the signal-averaging process. Total P wave duration was measured before and after filtering with a least squares fit filter. The P wave complexes on the three bipolar leads were combined into a vector combination of orthogonal leads. The total P wave duration of the individual unfiltered and filtered leads and the vector combination of filtered leads were calculated and used for analysis. RESULTS: The P wave duration by standard ECG was not significantly different in patients with a history of atrial fibrillation and control subjects. Signal-averaged P wave durations were measured from orthogonal leads before and after digital filtering. Mean unfiltered P wave duration was significantly longer in patients with a history of atrial fibrillation than in control subjects (132 +/- 22 vs. 114 +/- 14 ms [p < 0.03] in the X lead, 135 +/- 21 vs. 115 +/- 15 ms [p < 0.03] in the Y lead and 133 +/- 23 vs. 114 +/- 14 ms [p < 0.03] in the Z lead). Mean filtered P wave duration was also longer in patients with atrial fibrillation than in control subjects (151 +/- 23 vs. 130 +/- 19 ms [p < 0.01] in the X lead, 157 +/- 22 vs. 136 +/- 17 ms [p < 0.01] in the Y lead and 154 +/- 23 vs. 135 +/- 15 ms [p < 0.01] in the Z lead). After filtering, a vector composite of orthogonal leads was determined. Again, P wave duration in patients with a history of atrial fibrillation exceeded that in the control subjects (162 +/- 15 vs. 140 +/- 12 ms [p < 0.01]). Using the vector composite of filtered orthogonal leads, a P wave duration > or = 155 ms was associated with a sensitivity of 80%, a specificity of 93% and a positive predictive value of 92% for identifying patients with history of atrial fibrillation. CONCLUSIONS: A prolonged signal-averaged P wave duration may be a simple noninvasive marker of the risk for development of atrial fibrillation.
Authors: Olaf Dössel; Martin W Krueger; Frank M Weber; Mathias Wilhelms; Gunnar Seemann Journal: Med Biol Eng Comput Date: 2012-06-21 Impact factor: 2.602
Authors: Gautam G Lalani; Amir Schricker; Michael Gibson; Armand Rostamian; David E Krummen; Sanjiv M Narayan Journal: J Am Coll Cardiol Date: 2012-02-07 Impact factor: 24.094
Authors: Ulrik Dixen; Christian Joens; Bo V Rasmussen; Jan Parner; Gorm B Jensen Journal: Ann Noninvasive Electrocardiol Date: 2004-10 Impact factor: 1.468
Authors: J Kamata; K Nakai; N Chiba; S Hosokawa; Y Sato; M Nasu; T Sasaki; H Kitahara; H Izumoto; Y Yagi; C Itoh; K Hiramori; K Kawazoe Journal: Heart Date: 1997-01 Impact factor: 5.994
Authors: Paolo Caravelli; Marco De Carlo; Giuseppe Musumeci; Giuseppe Tartarini; Gherardo Gherarducci; Uberto Bortolotti; Massimo A Mariani; Mario Mariani Journal: Ann Noninvasive Electrocardiol Date: 2002-07 Impact factor: 1.468
Authors: Marco Budeus; Marcus Hennersdorf; Stefan Dierkes; Michael Preik; Matthias P Heintzen; Malte Kelm; Christian Perings Journal: Ann Noninvasive Electrocardiol Date: 2003-04 Impact factor: 1.468